Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonja Zweegman

Showing results (1-10 of 251) with videos related to

Pageof 26
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|March 25, 2011
[An immunocompromised man with a fever]Sandra Nathalie Stapel, Sonja Zweegman
Current Opinion in Oncology|August 2, 2017
Elderly patients with multiple myeloma: towards a frailty approach?Sonja Zweegman, Monika Engelhardt, Alessandra Larocca, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 5, 2011
[Volume replenishment in haemorrhage: caution advised]Albertus J Kooter, Sonja Zweegman, Yvo M Smulders
Bone|January 12, 2026
Models of myeloma bone disease: In vivo and in vitro approachesJiaxian Wang, Sonja Zweegman, Richard W J Groen
Lancet (London, England)|June 4, 2023
T-cell-engaging bispecific antibodies in cancerNiels W C J van de Donk, Sonja Zweegman
Hematology. American Society of Hematology. Education Program|December 7, 2024
Supportive care in myeloma-when treating the clone alone is not enoughSonja Zweegman, Niels W C J van de Donk
Hematology/Oncology Clinics of North America|December 27, 2023
Monoclonal Antibodies in the Treatment of Multiple MyelomaNiels W C J van de Donk, Sonja Zweegman
Leukemia|June 20, 2020
Defining the vulnerable patient with myeloma-a frailty position paper of the European Myeloma NetworkGordon Cook, Alessandra Larocca, Thierry Facon, et al.
Blood Cancer Discovery|September 17, 2025
The Two Sides of Bispecific Antibodies in Multiple Myeloma: Where Trial Promise Meets Real-World PracticeSonja Zweegman, Febe Smits, Niels W C J van de Donk
Critical Reviews in Oncology/Hematology|December 28, 2017
A question of class: Treatment options for patients with relapsed and/or refractory multiple myelomaGordon Cook, Sonja Zweegman, María-Victoria Mateos, et al.
Pageof 26

Showing results (1-10 of 251) with videos related to

Sort By:
Pageof 26
Nederlands Tijdschrift Voor Geneeskunde|March 25, 2011
[An immunocompromised man with a fever]Sandra Nathalie Stapel, Sonja Zweegman
Current Opinion in Oncology|August 2, 2017
Elderly patients with multiple myeloma: towards a frailty approach?Sonja Zweegman, Monika Engelhardt, Alessandra Larocca, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 5, 2011
[Volume replenishment in haemorrhage: caution advised]Albertus J Kooter, Sonja Zweegman, Yvo M Smulders
Bone|January 12, 2026
Models of myeloma bone disease: In vivo and in vitro approachesJiaxian Wang, Sonja Zweegman, Richard W J Groen
Lancet (London, England)|June 4, 2023
T-cell-engaging bispecific antibodies in cancerNiels W C J van de Donk, Sonja Zweegman
Hematology. American Society of Hematology. Education Program|December 7, 2024
Supportive care in myeloma-when treating the clone alone is not enoughSonja Zweegman, Niels W C J van de Donk
Hematology/Oncology Clinics of North America|December 27, 2023
Monoclonal Antibodies in the Treatment of Multiple MyelomaNiels W C J van de Donk, Sonja Zweegman
Leukemia|June 20, 2020
Defining the vulnerable patient with myeloma-a frailty position paper of the European Myeloma NetworkGordon Cook, Alessandra Larocca, Thierry Facon, et al.
Blood Cancer Discovery|September 17, 2025
The Two Sides of Bispecific Antibodies in Multiple Myeloma: Where Trial Promise Meets Real-World PracticeSonja Zweegman, Febe Smits, Niels W C J van de Donk
Critical Reviews in Oncology/Hematology|December 28, 2017
A question of class: Treatment options for patients with relapsed and/or refractory multiple myelomaGordon Cook, Sonja Zweegman, María-Victoria Mateos, et al.
Pageof 26